SAFETY AND EFFICACY OF EXENATIDE ONCE WEEKLY INJECTION VERSUS METFORMIN, DIPEPTIDYL PEPTIDASE-4 INHIBITOR, OR THIAZOLIDINEDIONE AS MONOTHERAPY IN DRUG-NAIVE PATIENTS WITH TYPE 2 DIABETES (DURATION-4):